Contact
日本語
Business
Next-Gen Medicine
Next-Gen Medicine
Pipeline
Technology/Program
Business Development
News
About Us
Career
Business
Next-Gen Medicine
Pipeline
Technology/Program
Business Development
News
About Us
Career
Contact
日本語
News
HOME
News
Release
Media
Stage
Other
2023.02.24
Release
NextGeM Presents at “4th Kyoto University LifeScience Showcase@ San Diego 2023”
2022.05.20
Release
NextGeM Initiated Non-invasive Prospective Study for Chromosome Aneuploidy Determination Software for Infertility Treatment
2022.04.22
Release
Participated in Center of Innovation NEXT（COI-NEXT）（bio area）
2022.01.11
Release
Joint R&D with Kyoto University on a prediction model for hematopoietic stem cell transplantation outcome using ensemble learning.
2021.11.17
Release
Joint research agreement with Mitsubishi Chemical Corporation on a cell culture method using plant-derived cell growth factors.
2021.11.17
Release
Joint R&D with Kyoto University on a prediction model for hematopoietic stem cell transplantation outcome using ensemble learning.
2021.09.27
Release
Obtained type 2 medical device manufacturing and sales license and medical device manufacturing license.
2021.05.26
Release
Selected as an AMED “Medical Innovation Promotion Project (Development and Commercialization Project) for Venture Development”.
2021.05.25
Release
“Non-clinical research on the improvement of the accuracy of bacterial species classification of bacterial infections and the appropriate use of antimicrobial drugs using image recognition AI” was adopted as a “Research Project for the Promotion of Medical Device Development”.
2021.05.06
Release
Selected for the 37th international conference of the European Society for Human Reproductive Research (ESHRE).
2021.03.29
Release
A subsidiary company, CarbGeM Inc. was established to address antimicrobial resistance.
2021.01.20
Release
Announced the interim evaluation results of Cyclic Innovation for Clinical Empowerment (CiCLE) at AMED
2020.10.21
Release
Joint R&D with National Center for Global Health and Medicine and Kobe University to estimate the bacterial species of infectious diseases and to support the selection of antimicrobial drugs by using AI.
2020.10.01
Release
CSO Miyanishi was appointed as a mentor for ANCHOR KOBE.
2020.09.23
Release
Joint R&D with Kyoto University for early diagnosis of malignant hematological diseases
2019.11.20
Release
Announced equity and business relationship with Sumitomo Dainippon Pharma Co., Ltd.(currently:Sumitomo Pharma Co., Ltd.).
2019.04.26
Release
“Development of in vitro expansion technology for hematopoietic stem cells and its application to transplantation medicine” was selected for Cyclic Innovation for Clinical Empowerment (CiCLE) at AMED.
2016.04.15
Release
NextGeM Inc. was established.
